ArticleBeijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences2026
[Preliminary clinical experience of domestic robot-assisted laparoscopic radical nephrectomy with venous tumor thrombectomy].
Article in Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo preliminarily investigate the safety and feasibility of domestic Jingfeng MP1000 multi-port robotic surgical system-assisted laparoscopic radical nephrectomy with venous tumor thrombectomy.
methodsClinical data of 15 patients with renal cell carcinoma (RCC) and venous tumor thrombus who underwent Jingfeng MP1000 robot-assisted laparoscopic radical nephrectomy with venous tumor thrombectomy at the Department of Urology, Peking University Third Hospital from June 2024 to January 2026 were retrospectively analyzed. The primary outcomes were the success rate of the robotic procedure, overall complication rate, and major complication rate (Clavien-Dindo ≥ grade Ⅲ). Secondary outcomes included operative time, estimated blood loss, and length of hospital stay. Baseline characteristics, perioperative outcomes, pathological results, and postoperative complications were collected and analyzed using descriptive statistical methods.
resultsAll the 15 procedures were successfully completed with robotic assistance, with no conversions to open surgery. The success rate of robotic-assisted surgery was 100%. The median patient age was 60 years, and the median body mass index was 25.6 kg/m
conclusionThe domestic Jingfeng MP1000 multi-port robotic system-assisted laparoscopic radical nephrectomy with venous tumor thrombectomy is technically safe and feasible, with favorable perioperative outcomes and a low complication rate. Its long-term oncological efficacy requires further validation through large-scale, prospective studies.
Indexed as
Identifiers
42493437PMC13402051What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.